The new vaccine approach will help improve survival rates for ‘the next decades and more’, says Cancer Research UK’s chief clinician The world’s first personalised …
Excitement among patients and researchers as custom-built jabs enter phase 3 trial Doctors have begun trialling in hundreds of patients the world’s first personalised mRNA …